טוען...
Predicting clinical outcomes in neuroblastoma with genomic data integration
BACKGROUND: Neuroblastoma is a heterogeneous disease with diverse clinical outcomes. Current risk group models require improvement as patients within the same risk group can still show variable prognosis. Recently collected genome-wide datasets provide opportunities to infer neuroblastoma subtypes i...
שמור ב:
| הוצא לאור ב: | Biol Direct |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6889397/ https://ncbi.nlm.nih.gov/pubmed/30621745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13062-018-0223-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|